Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2579950 | 0.81 | KMT2A (0.37) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL9297162 | 0.75 | NPSR1 (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL4467640 | 0.75 | NPSR1 (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL28001086 | 0.74 | ALDH1A1 (0.45) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL28217153 | 0.74 | NPSR1 (0.43) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL12562393 | 0.73 | KCNN4 (0.36) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL11454677 | 0.72 | ALDH1A1 (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL3279596 | 0.72 | NPSR1 (0.41) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL28750160 | 0.72 | ALDH1A1 (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL8706596 | 0.72 | MEN1 (0.38) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110256457-A1 | NONAQUEOUS SECONDARY BATTERY AND FLAME RETARDANT FOR THE SAME | SHARP KABUSHIKI KAISHA (JP) | 2011-10-20 | — | — | US | claimed |
| US-8592081-B2 | Nonaqueous secondary battery and flame retardant for the same | SHARP KABUSHIKI KAISHA (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20110256457-A1 | NONAQUEOUS SECONDARY BATTERY AND FLAME RETARDANT FOR THE SAME | SHARP KABUSHIKI KAISHA (JP) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256457-A1 | NONAQUEOUS SECONDARY BATTERY AND FLAME RETARDANT FOR THE SAME | NAF1, AFF1, KCNN2 | MEN1 3215/4885KMT2A 1169/4885SMN1; SMN2 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.